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Abstract
Background/Aims: Systemic hypertension is thought to increase the risk for developing open-angle glaucoma (OAG)
through several mechanisms. However, previous epidemiological studies have shown conflicting results regarding this
potential association. We systematically evaluated this issue by conducting a meta-analysis of population-based studies.
Methods: A comprehensive search for articles published before 31 March 2014 was performed using PubMed, Embase, and
reference lists. The pooled odds ratio (OR) was calculated using the fixed- and random-effects models, and meta-regression
was performed according to age. Subgroup analyses were also conducted, and publication bias was assessed using a funnel
plot and Egger’s regression test.
Results: This meta-analysis included 16 studies involving 60,084 individuals, with substantial homogeneity among the
studies. The pooled OR for OAG was 1.22 (95% confidence interval, CI: 1.09–1.36) using the fixed-effects model and 1.22
(95% CI: 1.08–1.37) using the random-effects model in all included studies. For subgroup analyses, the pooled OR for high-
tension glaucoma (HTG) was higher than that for normal-tension glaucoma (NTG) (OR= 1.92 and 0.94, respectively). No
significant difference was detected between Asian and Western populations, and no publication bias was detected in either
analysis.
Conclusions: Systemic hypertension increases the risk for developing OAG, especially in those with HTG.
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Introduction
Systemic hypertension (hereafter, hypertension) is a major
health issue affecting more than 25% of the adult population
worldwide; its prevalence is predicted to affect more than 1.5
billion individuals by 2025 [1,2]. Hypertension adversely affects
not only the heart and kidneys, but is also associated with a wide
range of major eye diseases, including glaucoma. Glaucoma is a
progressive and irreversible optic neuropathy characterized by
visual field loss, and is the second leading cause of blindness
worldwide after cataracts [3]. Hypertension is thought to increase
the risk of the development and progression of glaucoma [4–6],
and several mechanisms have been suggested to explain this
relationship. Direct microvascular damage caused by hypertension
could worsen blood flow to the anterior optic nerve [7].
Autoregulation of the posterior ciliary circulation could also be
impaired by hypertension [8]. In addition, antihypertensive
therapy could induce hypotensive episodes, especially at night,
which could injure the optic nerve [9].
Previous studies have shown incongruous results regarding an
association between hypertension and open-angle glaucoma
(OAG) [10–14]. In the Blue Mountains Eye Study [11],
hypertension increased the risk of OAG by more than 50% after
adjustment for other glaucoma risk factors such as intraocular
pressure (IOP). In addition, the Egna-Neumarkt Study [12] found
an association between diagnosis of OAG and hypertension.
However, Le et al. [13] found no association between hyperten-
sion and OAG; in fact, high blood pressure (BP) showed a trend
toward a negative relationship with OAG risk in the Barbados Eye
Studies [14]. Therefore, a systematic summary of the relationship
between hypertension and OAG is needed.
Most studies that have investigated the association between
hypertension and OAG have been observational studies. To the
best of our knowledge, no quantitative summary of this association
has been published. The overall aim of the present study was to
systematically evaluate the association between hypertension and
OAG by conducting a meta-analysis of all available and relevant
published studies.
Materials and Methods
Ethics Statement
This study followed the tenets of the Declaration of Helsinki.
The Institutional Review Board of our institute (Yonsei University
Health System) determined that this study was exempt from
requiring their approval.
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Figure 1. Flow chart of the literature search and selection criteria for inclusion in the meta-analysis. OR, odds ratio; OAG, open-
angle glaucoma.
doi:10.1371/journal.pone.0108226.g001
Figure 2. Forest plot of risk estimates for the association between systemic hypertension and open-angle glaucoma in all included
studies. CI, confidence interval.
doi:10.1371/journal.pone.0108226.g002
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Search Strategy
Two authors (HWB and NL) independently performed system-
atic PubMed and Embase literature searches of reports published
before 31 March 2014. The Preferred Reporting Items of the
Systematic Reviews and Meta-Analyses (PRISMA) statement was
followed in conducting this meta-analysis [15]. The following
search terms were used in PubMed: (‘‘hypertension’’[MeSH
Terms] OR ‘‘hypertension’’[All Fields]) AND (‘‘glaucoma’’[-
MeSH Terms] OR ‘‘glaucoma’’[All Fields]). For Embase,
‘‘hypertension’’/exp AND ‘‘glaucoma’’/exp were used as EM-
TREE terms. All retrieved studies from both PubMed and Embase
were exported into CSV files, and overlapping articles were
removed manually. The remaining studies were scanned based on
titles and abstracts to exclude those that were clearly irrelevant. All
inconsistencies were resolved by discussion and review of the
original articles. The full texts of the remaining studies were read
to check their eligibility. In addition, the reference lists of all
identified articles were examined.
Definition of OAG
OAG was defined as the presence of glaucomatous optic disc
change and/or visual field defects regardless of the IOP. Patients
with OAG had an open and normal appearing anterior chamber
and had no secondary causes. High-tension glaucoma (HTG) was
defined in patients with OAG with an IOP$22 mmHg, and
normal-tension glaucoma (NTG) was defined in patients with
OAG with an IOP,22 mmHg.
Inclusion and Exclusion Criteria
Studies included in this meta-analysis (1) were population-based,
(2) evaluated hypertension and OAG, and (3) reported odds ratios
(ORs) with 95% confidence intervals (CIs) to measure the
association between hypertension and OAG or showed the raw
data in the article to calculate the OR with 95% CI. Studies
excluded from this meta-analysis (1) were not reported in English,
(2) did not include hypertension as a risk factor for OAG, (3)
covered angle-closure glaucoma or secondary glaucoma or did not
clearly designate OAG, or (4) defined hypertension or glaucoma
based only medical records, questionnaire, or self-reported history.
When multiple publications reported the same population, only
the most recent study was included.
Data Extraction and Quality Assessment
Data were extracted from the studies by two independent
authors (HWB and NL). Disagreement was settled by discussion
and review of the articles. The following information was extracted
for each study: (1) the first author’s last name, (2) year of
publication, (3) country of study, (4) name of study population (if
available), (5) study design, (6) number of subjects (7) mean age of
subjects, (8) definition of hypertension, (9) type of glaucoma, (10)
effect size (OR and 95% CI), and (11) confounders used for
adjustment. We calculated the OR from raw data when no OR
was provided in the report. In most reports with more than one
effect size, we chose the OR adjusted for the largest number of
confounding factors. However, two ORs were extracted from the
Andhra Pradesh Eye Disease Study, in which urban and rural
cohorts were completely separated [16]. The study quality was
assessed by inverse-variance weighting.
Statistical Analysis
The pooled ORs with 95% CIs were estimated using the fixed-
and the random-effects models. The fixed-effects model is useful
when analyzing a sufficiently homogeneous group of studies,
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whereas the random-effects model is more appropriate when there
is heterogeneity among individual studies [17]. Heterogeneity
among studies was identified visually using a forest plot and
quantified statistically using the I2 index. The I2 index can be
interpreted as the percentage of the total variability in a set of
effect sizes due to true heterogeneity between studies [18].
Sensitivity analysis was also performed to evaluate the stability of
the meta-analysis. Omitting one study at a time, the pooled OR
for the remaining studies was calculated and compared to that of
the fixed- or random-effects model. Publication bias was evaluated
using Egger’s regression test and/or a funnel plot [19]. In addition,
meta-regression analysis was performed using age, which could
affect the prevalence of both hypertension and OAG. Subgroup
meta-analysis was carried out to evaluate each pooled OR in more
homogeneous subgroups and to identify characteristics of the
association between hypertension and OAG.
All statistical analyses were performed using Comprehensive
Meta-Analysis version 2.0 (Biostat, Inc., Englewood, NJ). A two-
sided P value of ,0.05 was considered to indicate statistical
significance.
Results
The primary literature search in PubMed and Embase
identified 8621 studies. After overlapping and irrelevant studies
were excluded through a title and abstract review, 185 potentially
relevant studies were investigated using a full-text review. Of these
studies, 13 met the inclusion criteria for the meta-analysis, and 3
additional eligible studies were found from the reference review.
Finally, 16 studies were enrolled in this meta-analysis (Figure 1)
[11,12,14,16,20–31].
Table 1 shows the characteristics of the enrolled studies. A
total of 60,084 subjects were included in this meta-analysis. The
mean ages of the included populations ranged from 51.0 to 70.8
years. The studies were published between 1995 and 2012, and all
studies were population-based: 15 were cross-sectional studies
[11,12,16,20–31] and one was a longitudinal cohort study [14].
Nine studies were performed on Asian populations [16,22–24,26–
29,31] and seven investigated Western populations
[11,12,14,20,21,25,30]. Hypertension was defined based on the
use of antihypertensive medication and/or the actual BP in all
studies. Two studies [12,25] indicated the ORs for OAG, HTG,
and NTG, while the remaining studies presented the OR for OAG
only.
The forest plot and I2 index indicated statistically significant
homogeneity (I2 = 7.5%, P=0.37) among all included studies for
OAG. The pooled OR was 1.22 (95% CI: 1.09–1.36) using the
fixed-effects model and 1.22 (95% CI: 1.08–1.37) using the
random-effects model (Figure 2). Sensitivity analysis showed that
no study had a strong influence on the pooled OR in this meta-
analysis (Table S1), and the funnel plot and Egger’s regression
test (P=0.90) indicated no obvious evidence of publication bias
(Figure 3A). Meta-regression analysis showed no significant
association between age and pooled OR (P=0.28) (Figure 4).
For the subgroup analysis, the pooled OR for HTG (hetero-
geneity; I2 = 0.0%) was 1.92 (95% CI: 1.28–2.87) using the fixed-
effects model, whereas that of NTG (heterogeneity; I2 = 28.4%)
was 0.99 (95% CI: 0.68–1.45) using the fixed-effects model and
0.94 (95% CI: 0.56–1.58) using the random-effects model
(Figure 5). The pooled OR from Asian populations (heterogene-
ity; I2 = 26.6%) was 1.20 (95% CI: 1.01–1.43) using the fixed-
effects model and 1.19 (95% CI: 0.97–1.46) using the random-
effects model, whereas that from Western populations (heteroge-
neity; I2 = 0.0%) was 1.23 (95% CI: 1.06–1.43) using the fixed-
effects model (Figure 6). No evidence of publication bias was
detected by Egger’s regression test (P=0.76 and 0.46, respectively)
or the funnel plot (Figure 3B and 3C).
Discussion
The present meta-analysis of population-based studies showed
that individuals with hypertension have an approximately 1.2-fold
higher risk of developing OAG than individuals without hyper-
tension. The pooled OR was 1.22 (95% CI: 1.09–1.36) using the
Figure 3. Funnel plots of the odds ratio of developing open-
angle glaucoma for identifying publication bias. Odds ratios are
displayed on a logarithmic scale. A, all included populations; B, Asian
populations; C, Western populations.
doi:10.1371/journal.pone.0108226.g003
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fixed-effects model and 1.22 (95% CI: 1.08–1.37) using the
random-effects model.
To maintain homogeneity among the included studies and to
minimize the possibility of selection bias, we enrolled only
population-based studies in this meta-analysis. Hospital-based
studies (which were mostly case-control studies) showed selection
bias, potentially because the individuals with hypertension had a
higher chance of greater access to the medical care system. Thus,
our meta-analysis maintained a high degree of homogeneity
among the studies (I2 = 7.5%, P=0.37).
Age is one of the most important confounding factors affecting
the prevalence of hypertension and OAG. The meta-regression
model was used to examine the impact of age on the effect size.
The results showed that age was not significantly associated with
the ORs in this meta-analysis (P=0.28). Therefore, hypertension
increased the risk of OAG development irrespective of age.
OAG has been considered a single disease because of the similar
properties between HTG and NTG [32–34]. In this study, we
performed subgroup meta-analyses for HTG and NTG to
evaluate the effects of IOP. Although only two studies were
enrolled, we found that the risk of developing HTG was increased
to a greater extent by hypertension than that of OAG, whereas the
risk of developing NTG was not affected by hypertension
(OR=1.92 and 0.94, respectively). This difference might be
Figure 4. Meta-regression analysis between the pooled odds ratio and age for open-angle glaucoma in all included studies. Odds
ratios are displayed on a logarithmic scale (P= 0.28).
doi:10.1371/journal.pone.0108226.g004
Figure 5. Subgroup analysis showing forest plot of risk estimates for the association between systemic hypertension and high-
tension glaucoma (top, A) and systemic hypertension and normal-tension glaucoma (bottom, B). CI, confidence interval.
doi:10.1371/journal.pone.0108226.g005
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attributable to the difference in IOP, which is related to ocular
perfusion pressure (OPP). Hypertension could be associated with
the development of OAG via two mechanisms. One mechanism
could be that increased BP leads to reduced ocular blood flow due
to thickening and stiffening of the vessels wall, therefore increasing
the risk of OAG [35]. The second mechanism is that a higher BP
produces a higher OPP, which could decrease the risk of OAG
[36]. Because OPP can be calculated as 2/3[(systolic BP+2diastolic
BP)/3] – IOP, it can be increased by high BP or low IOP. If two
subgroups had similarly high BPs, individuals with HTG might
have lower OPP than those with NTG. Therefore, it is thought
that the increased risk induced by hypertension might be
compensated by high OPP in individuals with NTG, and might
be strengthened by low OPP in those with HTG.
Another subgroup analysis according to country showed no
difference between Asian and Western populations. The ORs of
Asian and Western populations were both about 1.2, similar to
that for the total included population. Because NTG is more
common in Eastern than Western populations [37], it was
expected that the risk of developing OAG would be higher in
the Western than in the Asian population. However, this meta-
analysis showed no significant regional differences, although the
OR in Western populations was slightly higher than that in Asian
populations. Further studies considering BP and IOP are required
to evaluate the regional or ethnic differences regarding the
relationship between hypertension and OAG.
This meta-analysis had several limitations originating from the
individual studies and the meta-analysis itself. First, although the
funnel plot and Egger’s regression test demonstrated no evidence
of publication bias, our analyses were not entirely free from several
types of reporting bias [38]. For example, the possibility of
location, citation, and language biases could not be excluded.
Second, other unrevealed confounding factors or inadequate
control of such factors might have affected the ORs. Although we
Figure 6. Subgroup analysis showing forest plot of risk estimates for the association between systemic hypertension and open-
angle glaucoma in Asian (top, A) and Western populations (bottom, B). CI, confidence interval.
doi:10.1371/journal.pone.0108226.g006
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found that age (the most powerful confounding factor) showed no
association with the OR using meta-regression, we did not
consider all confounding factors. In addition, adjusted confound-
ing factors in each study varied among the included studies, and
some ORs were calculated from the raw data without adjustment.
This uneven management of confounding factors could have led to
overestimation or underestimation of the ORs. Finally, we could
not elucidate the precise correlation between OAG and the actual
BP or type of antihypertensive medication. However, this study
has clinical significance in that we targeted patients in our clinic
who were considered to have hypertension.
To the best of our knowledge, this study is the first meta-analysis
of the association between hypertension and OAG. This study
addressed the controversial issue regarding hypertension as a risk
factor for OAG and revealed that hypertension increases the risk
of developing OAG. Moreover, we revealed contradictory results
between HTG and NTG through the subgroup analysis.
Individuals with hypertension had the highest risk of developing
HTG because of low OPP induced by high IOP. Clinicians should
be aware of this possibility and give appropriate advice about
glaucoma evaluation to patients with hypertension.
In conclusion, the present meta-analysis of population-based
studies showed that systemic hypertension is a risk factor for OAG.
Although further research is needed, OAG should be taken into
account when treating individuals with hypertension.
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